Savvy Updates, 6/15/20: Inhalable Insulin Fewer Lows, Medtronic’s $337 Million Product Investment, T1D Wisdom in Pandemic
Hypoglycemia Is Reduced With Use of Inhaled Insulin Relative to Insulin Aspart in T1D A study found that participants treated with Afrezza experienced significantly fewer hypoglycemic events than participants treated with insulin aspart. Additionally, this reduction...
Savvy Updates, 6/8/20: Sea Snail Venom Fast Insulin?, Statins/Insulin Resistance, “Smart” Insulin Pens, Omnipod Horizon, Bad Insulin?, Nasal Glucagon
Sea snail venom used to create a new type of insulin was reported by Ryan Morrison for the DailyMail.co.uk, 1 June 2020. Insulin developed from the venom of a predatory sea snail could be used to create a ‘safer and more effective’ diabetes treatment,...
Savvy Updates, 6/1/20: Insulin Coupons, Less HbA1c variability with pump over MDI, Student invention for MDI
Why Insulin Coupons & CoPay Caps Aren’t Good Enough was reported by Ginger Vieira for InsulinNation.com, 28 May 2020. Novo Nordisk, Sanofi, and Eli Lilly reacted to insulin pricing outrage with modest and self-serving PR programs that do little; CMS is...
Savvy Updates, 4/27/20: Better D Care in Hospitals, Ambulatory Glucose Profile (AGP), Beta Cell Transplants for T1s
Demanding Better Diabetes Care in Hospitals was written by Mike Hoskins for DiabetesMine.com, 19 April 2020. This has been a problem for a long time … that’s what prompted me to write The Savvy Diabetic: A Survival Guide several years ago. ...
Savvy Update 4/13/20: Lilly Insulin for $35, Abbott Libre in Hospitals, Senseonics Eversense Off the Market
Eli Lilly lowers insulin costs as coronavirus crisis deepens, as reported by Reuters on CNBC.com, 7 April 2020. Drugmaker Eli Lilly said on Tuesday it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the United...
More Diabetes Blogs